Skip to main content
. 2009 Sep;11(6):483–492. doi: 10.1111/j.1477-2574.2009.00077.x

Table 2a.

Indications for total pancreatectomy (TP)

Summary (n= 47)
Malignant 23 (49%)
Pancreatic adenocarcinoma 20 (43%)
Pancreatic adenocarcinoma de novo 10 (21%)
Pancreatic adenocarcinoma with underlying IPMN 10 (21%)
Cholangiocarcinoma with IPMN 1 (2%)
Neuroendocrine tumour 1 (2%)
Renal cell carcinoma 1 (2%)
Non-malignant 24 (51%)
Non-invasive IPMN 21 (45%)
Chronic pancreatitis 2 (4%)
Trauma 1 (2%)

IPMN, intraductal papillary mucinous neoplasms.